Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Stephen V. Faraone, Ph.D.

Co-Author

This page shows the publications co-authored by Stephen Faraone and Benjamin Neale.
Connection Strength

4.079
  1. Perspective on the genetics of attention deficit/hyperactivity disorder. . 2008 Dec 05; 147B(8):1334-6.
    View in: PubMed
    Score: 0.407
  2. Genome-wide association scan of attention deficit hyperactivity disorder. . 2008 Dec 05; 147B(8):1337-44.
    View in: PubMed
    Score: 0.407
  3. Population differences in the International Multi-Centre ADHD Gene Project. Genet Epidemiol. 2008 Feb; 32(2):98-107.
    View in: PubMed
    Score: 0.384
  4. Exome sequencing in schizophrenia-affected parent-offspring trios reveals risk conferred by protein-coding de novo mutations. Nat Neurosci. 2020 02; 23(2):185-193.
    View in: PubMed
    Score: 0.220
  5. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat Genet. 2019 01; 51(1):63-75.
    View in: PubMed
    Score: 0.203
  6. A Genetic Investigation of Sex Bias in the Prevalence of Attention-Deficit/Hyperactivity Disorder. Biol Psychiatry. 2018 06 15; 83(12):1044-1053.
    View in: PubMed
    Score: 0.190
  7. Genome-wide association study of blood pressure response to methylphenidate treatment of attention-deficit/hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30; 35(2):466-72.
    View in: PubMed
    Score: 0.117
  8. Case-control genome-wide association study of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010 Sep; 49(9):906-20.
    View in: PubMed
    Score: 0.114
  9. Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010 Sep; 49(9):884-97.
    View in: PubMed
    Score: 0.114
  10. Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010 Sep; 49(9):898-905.e3.
    View in: PubMed
    Score: 0.112
  11. Genome-wide association studies in ADHD. Hum Genet. 2009 Jul; 126(1):13-50.
    View in: PubMed
    Score: 0.104
  12. Genome-wide association study of response to methylphenidate in 187 children with attention-deficit/hyperactivity disorder. . 2008 Dec 05; 147B(8):1412-8.
    View in: PubMed
    Score: 0.102
  13. Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. . 2008 Dec 05; 147B(8):1345-54.
    View in: PubMed
    Score: 0.102
  14. Does parental expressed emotion moderate genetic effects in ADHD? An exploration using a genome wide association scan. . 2008 Dec 05; 147B(8):1359-68.
    View in: PubMed
    Score: 0.102
  15. Genome-wide association scan of the time to onset of attention deficit hyperactivity disorder. . 2008 Dec 05; 147B(8):1355-8.
    View in: PubMed
    Score: 0.102
  16. Genetic heterogeneity in ADHD: DAT1 gene only affects probands without CD. Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 05; 147B(8):1481-7.
    View in: PubMed
    Score: 0.102
  17. Linkage to chromosome 1p36 for attention-deficit/hyperactivity disorder traits in school and home settings. Biol Psychiatry. 2008 Oct 01; 64(7):571-6.
    View in: PubMed
    Score: 0.097
  18. A high-density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16. Mol Psychiatry. 2008 May; 13(5):514-21.
    View in: PubMed
    Score: 0.096
  19. Correction to: Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality. Mol Psychiatry. 2021 Jul; 26(7):3663.
    View in: PubMed
    Score: 0.061
  20. Author Correction: Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder. Nat Commun. 2021 Feb 15; 12(1):1166.
    View in: PubMed
    Score: 0.059
  21. Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder. Nat Commun. 2021 01 25; 12(1):576.
    View in: PubMed
    Score: 0.059
  22. Examining Sex-Differentiated Genetic Effects Across Neuropsychiatric and Behavioral Traits. Biol Psychiatry. 2021 06 15; 89(12):1127-1137.
    View in: PubMed
    Score: 0.059
  23. Investigating Shared Genetic Basis Across Tourette Syndrome and Comorbid Neurodevelopmental Disorders Along the Impulsivity-Compulsivity Spectrum. Biol Psychiatry. 2021 09 01; 90(5):317-327.
    View in: PubMed
    Score: 0.059
  24. Comparative genetic architectures of schizophrenia in East Asian and European populations. Nat Genet. 2019 12; 51(12):1670-1678.
    View in: PubMed
    Score: 0.054
  25. Genetic Markers of ADHD-Related Variations in Intracranial Volume. Am J Psychiatry. 2019 03 01; 176(3):228-238.
    View in: PubMed
    Score: 0.052
  26. Advanced Paternal Age and Early Onset of Schizophrenia in Sporadic Cases: Not Confounded by Parental Polygenic Risk for Schizophrenia. Biol Psychiatry. 2019 07 01; 86(1):56-64.
    View in: PubMed
    Score: 0.051
  27. Disentangling polygenic associations between attention-deficit/hyperactivity disorder, educational attainment, literacy and language. Transl Psychiatry. 2019 01 24; 9(1):35.
    View in: PubMed
    Score: 0.051
  28. Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality. Mol Psychiatry. 2020 10; 25(10):2493-2503.
    View in: PubMed
    Score: 0.051
  29. Analysis of shared heritability in common disorders of the brain. Science. 2018 06 22; 360(6395).
    View in: PubMed
    Score: 0.049
  30. Polygenic risk for schizophrenia and neurocognitive performance in patients with schizophrenia. Genes Brain Behav. 2018 01; 17(1):49-55.
    View in: PubMed
    Score: 0.046
  31. Genetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder. Proc Natl Acad Sci U S A. 2014 Apr 22; 111(16):5968-73.
    View in: PubMed
    Score: 0.037
  32. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013 Sep; 45(9):984-94.
    View in: PubMed
    Score: 0.035
  33. High loading of polygenic risk for ADHD in children with comorbid aggression. Am J Psychiatry. 2013 Aug; 170(8):909-16.
    View in: PubMed
    Score: 0.035
  34. Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants. Am J Med Genet B Neuropsychiatr Genet. 2013 Jul; 162B(5):419-430.
    View in: PubMed
    Score: 0.035
  35. Common obesity risk alleles in childhood attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2013 Jun; 162B(4):295-305.
    View in: PubMed
    Score: 0.034
  36. Genome-wide association study in German patients with attention deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2011 Dec; 156B(8):888-97.
    View in: PubMed
    Score: 0.031
  37. On genome-wide association studies for family-based designs: an integrative analysis approach combining ascertained family samples with unselected controls. Am J Hum Genet. 2010 Apr 09; 86(4):573-80.
    View in: PubMed
    Score: 0.028
  38. Conduct disorder and ADHD: evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study. . 2008 Dec 05; 147B(8):1369-78.
    View in: PubMed
    Score: 0.025
  39. Non-random error in genotype calling procedures: implications for family-based and case-control genome-wide association studies. Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 05; 147B(8):1379-86.
    View in: PubMed
    Score: 0.025
  40. Differential dopamine receptor D4 allele association with ADHD dependent of proband season of birth. . 2008 Jan 05; 147B(1):94-9.
    View in: PubMed
    Score: 0.024
  41. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry. 2006 Oct; 11(10):934-53.
    View in: PubMed
    Score: 0.022
  42. The IMAGE project: methodological issues for the molecular genetic analysis of ADHD. Behav Brain Funct. 2006 Aug 03; 2:27.
    View in: PubMed
    Score: 0.022
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.